Neurology 2001;56:849-855
© 2001 American Academy of Neurology
Articles
Familial cerebellar ataxia with muscle coenzyme Q10 deficiency
O. Musumeci, MD;,
A. Naini, PhD;,
A. E. Slonim, MD;,
N. Skavin, PT;,
G. L. Hadjigeorgiou, MD;,
N. Krawiecki, MD;,
B. M. Weissman, MD;,
C.-Y. Tsao, MD;,
J. R. Mendell, MD;,
S. Shanske, PhD;,
D. C. De Vivo, MD;,
M. Hirano, MD; and
S. DiMauro, MD
From the Department of Neurology (Drs. Musumeci, Naini, Shanske, De Vivo, Hirano, and DiMauro), Columbia University College of Physicians and Surgeons, New York, NY; Department of Pediatrics (Dr. Slonim and N. Skavin), North Shore University Hospital, Manhasset, NY; Department of Pediatrics (Drs. Krawiecki and Weissman), Emory University, Atlanta, GA; Children’s Hospital (Dr. Tsao), Columbus, OH; and Department of Neurology (Dr. Mendell), Ohio State University, Columbus.
Address correspondence and reprint requests to Dr. Salvatore DiMauro, 4-420 College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032; e-mail: sd12{at}columbia.edu
OBJECTIVE: To describe a clinical syndrome of cerebellar ataxia associated with muscle coenzyme Q10 (CoQ10) deficiency.
BACKGROUND: Muscle CoQ10 deficiency has been reported only in a few patients with a mitochondrial encephalomyopathy characterized by 1) recurrent myoglobinuria; 2) brain involvement (seizures, ataxia, mental retardation), and 3) ragged-red fibers and lipid storage in the muscle biopsy.
METHODS: Having found decreased CoQ10 levels in muscle from a patient with unclassified familial cerebellar ataxia, the authors measured CoQ10 in muscle biopsies from other patients in whom cerebellar ataxia could not be attributed to known genetic causes.
RESULTS: The authors found muscle CoQ10 deficiency (26 to 35% of normal) in six patients with cerebellar ataxia, pyramidal signs, and seizures. All six patients responded to CoQ10 supplementation; strength increased, ataxia improved, and seizures became less frequent.
CONCLUSIONS: Primary CoQ10 deficiency is a potentially important cause of familial ataxia and should be considered in the differential diagnosis of this condition because CoQ10 administration seems to improve the clinical picture.
This article has been cited by other articles:
|
|
|
|
 
S Rahman and M G Hanna
Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases
J. Neurol. Neurosurg. Psychiatry,
September 1, 2009;
80(9):
943 - 953.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Quinzii, L. C. Lopez, J. Von-Moltke, A. Naini, S. Krishna, M. Schuelke, L. Salviati, P. Navas, S. DiMauro, and M. Hirano
Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency
FASEB J,
June 1, 2008;
22(6):
1874 - 1885.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Diomedi-Camassei, S. Di Giandomenico, F. M. Santorelli, G. Caridi, F. Piemonte, G. Montini, G. M. Ghiggeri, L. Murer, L. Barisoni, A. Pastore, et al.
COQ2 Nephropathy: A Newly Described Inherited Mitochondriopathy with Primary Renal Involvement
J. Am. Soc. Nephrol.,
October 1, 2007;
18(10):
2773 - 2780.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-Y. Tsao and J. R. Mendell
Autistic Disorder in 2 Children With Mitochondrial Disorders
J Child Neurol,
September 1, 2007;
22(9):
1121 - 1123.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. J. Duncan, S. J.R. Heales, K. Mills, S. Eaton, J. M. Land, and I. P. Hargreaves
Determination of Coenzyme Q10 Status in Blood Mononuclear Cells, Skeletal Muscle, and Plasma by HPLC with Di-Propoxy-Coenzyme Q10 as an Internal Standard
Clin. Chem.,
December 1, 2005;
51(12):
2380 - 2382.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Lamperti, A. B. Naini, V. Lucchini, A. Prelle, N. Bresolin, M. Moggio, M. Sciacco, P. Kaufmann, and S. DiMauro
Muscle Coenzyme Q10 Level in Statin-Related Myopathy
Arch Neurol,
November 1, 2005;
62(11):
1709 - 1712.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Salviati, S. Sacconi, L. Murer, G. Zacchello, L. Franceschini, A. M. Laverda, G. Basso, C. Quinzii, C. Angelini, M. Hirano, et al.
Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: A CoQ10-responsive condition
Neurology,
August 23, 2005;
65(4):
606 - 608.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Quinzii, A. G. Kattah, A. Naini, H. O. Akman, V. K. Mootha, S. DiMauro, and M. Hirano
Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation
Neurology,
February 8, 2005;
64(3):
539 - 541.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Lalani, G. D. Vladutiu, K. Plunkett, T. E. Lotze, A. M. Adesina, and F. Scaglia
Isolated Mitochondrial Myopathy Associated With Muscle Coenzyme Q10 Deficiency
Arch Neurol,
February 1, 2005;
62(2):
317 - 320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Aure, J. F. Benoist, H. O. de Baulny, N. B. Romero, O. Rigal, and A. Lombes
Progression despite replacement of a myopathic form of coenzyme Q10 defect
Neurology,
August 24, 2004;
63(4):
727 - 729.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Rundek, A. Naini, R. Sacco, K. Coates, and S. DiMauro
Atorvastatin Decreases the Coenzyme Q10 Level in the Blood of Patients at Risk for Cardiovascular Disease and Stroke
Arch Neurol,
June 1, 2004;
61(6):
889 - 892.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Gironi, C. Lamperti, R. Nemni, M. Moggio, G. Comi, F. R. Guerini, P. Ferrante, N. Canal, A. Naini, N. Bresolin, et al.
Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency
Neurology,
March 9, 2004;
62(5):
818 - 820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. DiMauro and E. A. Schon
Mitochondrial Respiratory-Chain Diseases
N. Engl. J. Med.,
June 26, 2003;
348(26):
2656 - 2668.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Lamperti, A. Naini, M. Hirano, D.C. De Vivo, E. Bertini, S. Servidei, M. Valeriani, D. Lynch, B. Banwell, M. Berg, et al.
Cerebellar ataxia and coenzyme Q10 deficiency
Neurology,
April 8, 2003;
60(7):
1206 - 1208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Arenas, M.A. Fernandez-Moreno, J.A. Molina, V. Fernandez, P. del Hoyo, Y. Campos, P. Calvo, M.A. Martin, A. Garcia, T. Moreno, et al.
Myoglobinuria and COX deficiency in a patient taking cerivastatin and gemfibrozil
Neurology,
January 14, 2003;
60(1):
124 - 126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. W. Shults, D. Oakes, K. Kieburtz, M. F. Beal, R. Haas, S. Plumb, J. L. Juncos, J. Nutt, I. Shoulson, J. Carter, et al.
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Arch Neurol,
October 1, 2002;
59(10):
1541 - 1550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Rozen, M. Oshinsky, C. Gebeline, K. Bradley, W. Young, A. Shechter, and S. Silberstein
Open Label Trial of Coenzyme Q10 as A Migraine Preventive
Cephalalgia,
March 1, 2002;
22(2):
137 - 141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.W. Shults and A.H.V. Schapira
A cue to queue for CoQ?
Neurology,
August 14, 2001;
57(3):
375 - 376.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Di Giovanni, M. Mirabella, A. Spinazzola, P. Crociani, G. Silvestri, A. Broccolini, P. Tonali, S. Di Mauro, and S. Servidei
Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency
Neurology,
August 14, 2001;
57(3):
515 - 518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
